Portfolio

Orthovita

Orthopedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies


Orthovita, Inc. was a specialty spine and orthopedic company with a portfolio of orthobiologic and biosurgery products that developed and marketed innovative medical implants. The company’s products are based on novel and unique proprietary biomaterials that have innovative mechanisms of action in the body.  Orthovita’s orthobiologics platform offers products for the fusion, regeneration and fracture fixation of human bone, while its biosurgery platform offers products for controlling intra-operative bleeding, also known as hemostasis.  The main products in Orthovita’s orthobiologics portfolio include Vitoss and Cortoss and in the biosurgery portfolio, Vitagel and Vitasure.  The company is based in Malvern, Pennsylvania.

Transaction Summary

  • In 2007, Essex Woodlands led a multidimensional deal which included leading a $32.5M PIPE; buying back a royalty interest; obtaining $45M in debt financing and recruiting leading industry executives to the board.
  • In May 2011, the company entered into an agreement to be acquired by Stryker Corporation for $316M.
  • Malvern, PA
  • NASDAQ: VITA

  • Contact:
    Scott Barry
  • www.stryker.com
  • Acquisition
  • Acquired by: Stryker Corporation
  • Exit date: May 17, 2011
  • Logo

Related News